Please use this identifier to cite or link to this item:
Title: Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures
Authors: Angthong C.
Rodjanawijitkul S.
Samart S.
Angthong W.
Keywords: bisphosphonic acid derivative
bone density conservation agent
calcium derivative
vitamin D
bone density
drug combination
femur fracture
follow up
lumbar vertebra
middle aged
photon absorptiometry
retrospective study
spine fracture
treatment outcome
utilization review
Absorptiometry, Photon
Bone Density
Bone Density Conservation Agents
Calcium Compounds
Drug Therapy, Combination
Femoral Fractures
Follow-Up Studies
Fractures, Bone
Lumbar Vertebrae
Middle Aged
Retrospective Studies
Spinal Fractures
Treatment Outcome
Vitamin D
Issue Date: 2013
Abstract: Objective: The aim of this study was to report the prevalence of post-fracture bone mineral density (BMD) testing and osteoporosis treatment in patients admitted to the orthopedic department for lowenergy or high-energy fractures and to identify factors affecting prevalence of post-fracture BMD testing and osteoporosis treatment. Methods: A total of 265 patients aged 45 years or older admitted with low-energy or high-energy fractures were reviewed between January 2010 and May 2011. Information regarding age, gender, fracture site and history of post-fracture BMD testing and osteoporosis treatment, including data reporting experiences of attending orthopedists (young: <10, senior: >10 years of experience) were recorded. Results: Of the 265 patients (175 female, 90 male), 259 (97.7%) patients had low-energy fractures and 6 (2.3%) suffered high-energy fractures. Of 259 low-energy fractures, 99 (38.2%) underwent BMD testing and had mean total T-scores of -2.04±1.01 (proximal-femur) and -2.12±1.27 (lumbar-spine). Only one high-energy fracture patient (16.7%) underwent BMD testing, with a T-score of -1.1 (proximal- femur) and -2.7 (lumbar-spine). Eighty-six (32.5%) patients (85 low-energy fractures; 1 highenergy fracture) with diagnosis of osteopenia/osteoporosis from BMD testing were treated with calcium, vitamin D, and bisphosphonates. Bone mineral density testing was significantly higher in lowenergy fracture patients who were treated by a young orthopedist, a common fracture site (proximalfemur, distal-radius, vertebrae) or were female (p<0.05). Conclusion: Bone mineral density investigation and treatment rates are currently suboptimal. The current gap in adequate care necessitates multidisciplinary intervention in order to lessen the incidence of future fractures, particularly in patients over the age of 45. © 2013 Turkish Association of Orthopaedics and Traumatology.
ISSN: 1017995X
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.

Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.